Clinical Trial Update: Metformin in the Diastolic Dysfunction of Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on metformin for diastolic dysfunction in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Universidade do Porto | Conditions: Metabolic Syndrome X, Diastolic Dysfunction | Phase 2 | Status: COMPLETED